About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, February 24th, 2015

The QualityStocks
Daily Stock List


Medizone International, Inc. (MZEI)

PennyStocks24, Stock Brain, HEROSTOCKS, VIP STOCK ALERTS, Stockhunter.us, and Liquid Pennies reported earlier on Medizone International, Inc. (MZEI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Medizone International, Inc. and its’ subsidiaries have been a development stage company conducting research into the use of ozone in the disinfection of surgical and other medical treatment facilities and in other applications. During 2012, the Company emerged from the development stage. It started to sell its patented ozone disinfection system, AsepticSure®. Medizone International has its headquarters in Sausalito, California. The Company’s shares trade on the OTC Bulletin Board.

Medizone International’s BSL2A certified laboratory is located at Innovation Park, Queen’s University in Kingston, Ontario. It provides a primary research and development platform for the Company.

The AsepticSure® hospital sterilization system is a portable, affordable, easily operated system. It can be used by trained maintenance staff and it is placed in the center of the room to be cleaned.  Vents and doors are then sealed with an easily and cleanly removable 3M-tape product.

The system is turned on from outside of the room through a remote wireless computer interface. The room is filled with a unique and patented gas formula, which is ozone-based to specific humidity and charge strength. The sterilization process is remotely turned off after the charge period and a separate technology is employed that restores the atmosphere inside the room to EPA standards.

After December 31, 2012, Singapore issued Medizone International its Health Care Patent. The Company considers this significant for its business growth in Asia. Medizone believes Singapore could become a lucrative market for AsepticSure® sales.

The medical system in Singapore looks to distinguish itself with the safest hospitals possible to promote continued growth in the expanding medical tourism market. Medizone took delivery at the end of January 2013 of the first AsepticSure® system built by its new contract manufacturer, Transformix Engineering.

In January 2014, Medizone International announced that it was granted its fourth patent for its AsepticSure®. The United States Patent and Trademark Office (USPTO) issued US Patent number 8,636,951 titled “Bio-Terrorism Counteraction Using Ozone and Hydrogen Peroxide”.

This past December, Medizone International, in the Year End Chairman’s Message said that more recently, viral infections including Ebola and MERS coronavirus have also raised worldwide concern, especially in the Middle East and West Africa. The Company said that it has reached a point in which the AsepticSure approach of avoiding the infection in the first place is now being seriously considered as significant hospital players and international healthcare companies review options to lower infection rates, and importantly from the corporate standpoint, how to grow revenue streams in the face of these challenges.

Medizone International, Inc. (MZEI), closed Tuesday's trading session at $0.0999, up 13.65%, on 77,110 volume with 8 trades. The average volume for the last 60 days is 163,336 and the stock's 52-week low/high is $0.075/$0.294.

Solaris Power Cells, Inc. (SPCL)

Pumps and Dumps, Breaking Bulls, SMS Penny Picks, Psycho Penny Stocks, AwesomeStocks, Penny Stock Craze, Investor Soup, Stock Preacher, Penny Stocks Finder, Beacon Equity Research, and SuperStockTips reported earlier on Solaris Power Cells, Inc. (SPCL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Solaris Power Cells, Inc. is a developmental stage diversified "green" energy storage manufacturer that lists on the OTCQB. It provides commercial and residential users’ turnkey, renewable energy storage solutions. The Company was previously known as Rolling Technologies, Inc. It changed its name to Solaris Power Cells, Inc. in August of 2013. Founded in 2007, Solaris Power Cells has its headquarters in Palm Springs, California.

The Company’s corporate mission is to provide pioneering, effective solutions for the Solar Storage industry; provide environmentally sustainable products and solutions, and create a value proposition for its customers and make a positive impact on their respective businesses.

The Company manufactures the Solaris PESA™ "Passive Electron Storage Array"™, for limited use electric vehicles such as golf cars. The Solaris PESA™ is a 100 percent lead-free, solid-state storage solution. It makes renewable energy greener and better by permitting applications to use more of the energy generated.

The Solaris Power Cell™ is capable of providing energy storage to applications usually reliant and equipped with highly toxic lead acid, nickel metal hydride or lithium-ion batteries. The Solaris Power Cells renewable solar energy storage solution replaces expensive toxic, lead acid or lithium-ion batteries. In addition, this solution stores electricity instantly.

The Company’s PESA-CELLS are rated for over 1,000,000 cycles. This leads to being maintenance free for 10 years. Moreover, all of its energy storage products will have a minimum of 15 years limited lifetime warranty.

This past December, Solaris Power Cells reported joint Research & Development (R&D) with Sac Tec Solar, commencing this first quarter of 2015. Sac Tec looks to incorporate Solaris Power Cells Storage Arrays and satisfy increasing demand for Sac Tec mobile energy products. Sac Tec Solar is a foremost manufacturer and systems integrator of mobile solar sun-tracking iso-containerized energy solutions for remote off-grid, life critical, and emergency applications. It has locations in Frederick, Maryland, and Torrance and Palm Springs, California.

Solaris Power Cells, Inc. (SPCL), closed Tuesday's trading session at $0.08, up 40.11%, on 551,913 volume with 52 trades. The average volume for the last 60 days is 177,417 and the stock's 52-week low/high is $0.025/$0.899.

Gamzio Mobile, Inc. (GAMZ)

Penny Pick Insider, Penny Stocks VIP, Daily Stock Motion, Wallstreet Profiler, PennyDoctor, Greenbackers, and SmallCapVoice reported earlier on Gamzio Mobile, Inc. (GAMZ), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Gamzio Mobile, Inc. is a mobile and social casino gaming company that lists on the OTCQB. Its emphasis is pioneering mobile casino games.  Slots-O-Luck (US IOS Available) and Casino Island Adventure (UK) are its first products to launch. Gamzio Mobile’s mission is to bring a genuine "Vegas" experience to the mobile gaming market through a strategic approach that optimizes real-time data and analytics technology. The Company is based in Nevada.

Gamzio Mobile employs proprietary Social Integration Systems in its games. Therefore, this creates unique social experiences for players around the world. Gamzio is working to aggressively grow via strategic acquisitions and organic player acquisition. The Company focuses on collaboration with veterans from top online game companies and best of breed technology integration.

Gamzio Mobile announced in May 2014 that it acquired the Facebook social casino app Go-Go Casino. The Go-Go Casino App is now in redevelopment by the Gamzio DevOps Team.  Gamzio Mobile is now working behind the scenes of Go-Go's current casino operations to update functions and install upgrades and enhancements to gameplay.

The Company is also deploying proven optimization frameworks from its other successful games. Gamzio's integration with Facebook can be leveraged to provide an expanded set of features and experiences for its players. This is while expanding Gamzio’s reach to browser-based online games.

Gamzio Mobile announced in 2014 that its’ new real-money game: "Casino Island Adventure" is live in the U.K. Apple App Store. Gamzio is working to tap into the $3.4 Billion UK online gambling industry. This game successfully completed compliance review by gaming authorities. Gamzio’s priorities in entering the iGaming sector are first-rate customer service, fast and secure banking transactions, as well as exclusive gaming content.

Gamzio partnered with licensed eGambling company CashBet last year. This is to provide licensing, compliance, secure banking, and customer service for Casino Island Adventure. CashBet's Alderney gaming licenses and platform permit Gamzio Mobile to integrate its exclusive game content, and legally operate in approved jurisdictions such as the UK.

Gamzio Mobile announced this past November strong initial traction with its UK based Real-Money game: Casino Island Adventure. The Company’s first Real-Money game offering launched on the UK Apple App Store in Q2 of 2014. Gamzio announced its debut title in the $3.9 billion UK online gambling space is showing excellent engagement and monetization.

Gamzio Mobile, Inc. (GAMZ), closed Tuesday's trading session at $0.02, down 20.63%, on 58,656 volume with 9 trades. The average volume for the last 60 days is 9,119 and the stock's 52-week low/high is $0.02/$0.43.

Lithium Corp. (LTUM)

SmarTrend Newsletters reported earlier on Lithium Corp. (LTUM), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Lithium Corp. concentrates on the discovery and development of lithium and related mineral resources. Currently, it is exploring two wholly owned prospects in Nevada. On each prospect, the Company has defined a lithium-in-brine anomaly. Lithium’s dedication is to the exploration for new lithium ion battery related resources in western North America. The OTCQB-listed Company is based in Las Vegas, Nevada.

Lithium’s projects include BC Sugar, Mt Heimdal, Hughes Property, Fish Lake Valley, and San Emidio. BC Sugar is a graphite property in Shuswap, British Columbia. At its flagship Fish Lake Valley, the Company holds Placer claims that cover approximately 6,400 acres. Fish Lake Valley is in West Central Nevada, in Northern Esmeralda County.

At Fish Lake Valley, a lithium/boron/potassium anomaly was discovered. The drilling programs outlined a lithium anomaly of 450 meters by 750 meters. This is not yet fully delimited. Additionally, Lithium’s drilling program delineated boron and potassium values averaging 992.7 mg/L and 0.535 percent, respectively. 

Concerning San Emidio, the Company staked a 1,600-acre block of 20 claims in the San Emidio Valley during September 2011. These claims cover the most prospective portion of the playa. This is where continuing sampling has determined anomalous concentrations of lithium occur in sediments and in brines. The San Emidio Project is in northwestern Nevada, Washoe County.

The Company has increased the size of the BC Sugar property to approximately 19,664 acres (7,957 hectares). A number of graphite prospects have been discovered in a belt of metamorphic rocks that stretches at least 8 miles (13 kms) through the claim block.

Lithium announced in April of 2014 that it acquired an indirect 25 percent interest in several patented mining claims that come from the once extensive holdings of Howard Hughes. It participated in the formation of Summa LLC, a new private Nevada Limited Liability company, which holds 88 fee-title patented lode claims that cover around 1,191.3 acres of prospective mineral lands.

In August 2014, Lithium announced that an exploration crew was mobilized to explore the Company’s Mt Heimdal flake graphite property in British Columbia. The 2014 program focused on flake graphite mineralization discovered on the property during the brief program which took place in 2013.

Lithium maintains a strategic alliance with Altura Mining, an ASX listed coal producer, which recently approved the divestiture of its’ Mt. Weber iron asset, and the spin-off of its coal assets into a Singapore listed company. Furthermore, Altura is looking for off-take contracts for its 100 percent owned world-class Pilgangoora lithium pegmatite property in Western Australia.

Last week, Lithium announced the start of the field work portion of a generative program. Soil and brine samples will be taken at different locations that are prospective for lithium mineralization. The purpose of the program is to commence evaluating the properties for potential acquisition.

Lithium Corp. (LTUM), closed Tuesday's trading session at $0.0461, even for the day, on 293,098 volume with 31 trades. The average volume for the last 60 days is 104,365 and the stock's 52-week low/high is $0.021/$0.183.

Acology, Inc. (ACOL)

Greenbackers, Orbit Stocks, Penny Pick Insider, Penny Stocks VIP, Daily Stock Motion, SMS Penny Picks, Wall Street Beauties, FatCat Stocks, and WINNINGOTC reported this month on Acology, Inc. (ACOL), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Corona, California-based Acology, Inc. is a bottle design, manufacturing, branding and sales company. It is bringing to the forefront the first-ever polypropylene (PP) airtight, watertight, smell-proof delivery and storage system with a built-in grinding component. This is the MedTainer™, which Acology markets and sells. Target markets for the MedTainer™ include Private and Compounding Pharmacies, Oriental and Traditional Herbal Pharmacists, and Veterinary Clinicians. Acology lists on the OTC Markets’ OTCQB
The MedTainer™ is manufactured from medical-grade No. 5 polypropylene resin. This is non-porous and non-leaching. These containers are portable. The Company markets the MedTainer™ through distributors in the U.S. and Canada and over its website, www.themedtainer.com.  The 4th and 5th generation MedTainer is patented and Food and Drug Administration (FDA) approved.

The MedTainer™ is child resistant and it features a built-in grinder that grinds pills, herbal medications, coffee beans, as well as teas into fine powder. The container's grinding teeth have been reinforced for greater wear and simpler manipulation. The Rein Group, Inc. conducted tests, and it was established that pills large and small were easily made into powder form in less than 30 seconds. Enteric-coated pills and pills that are not easily crushed or cut in half were also easily reduced to powder in less than 30 seconds.

With Acology containers, consumers can easily store, carry, and consume herbal remedies, pharmaceuticals, teas, and any other solid or liquid content. Acology adheres closely to the rigid compliance standards of the medical industry. Therefore, it can provide the medical professional with the ability to store, mix, and distribute medications in solid form without the fear of cross-contamination.

Last week, Acology announced that it recently launched an aggressive retail growth initiative because of the high demand of its signature product, the MedTainer™. Acology released its newly redesigned retail website (www.themedtainer.com) and adopted a new refrain," Package Responsibly." Furthermore, the Company hired a top-shelf E-Commerce team to help capitalize on the opportunities within the retail side.

Acology, Inc. (ACOL), closed Tuesday's trading session at $0.0105, up 72.13%, on 5,162,651 volume with 193 trades. The average volume for the last 60 days is 628,300 and the stock's 52-week low/high is $0.002/$5.00.

Bio-AMD, Inc. (BIAD)

Today we are reporting on Bio-AMD, Inc. (BIAD), here at the QualityStocks Daily Newsletter.

OTCQB-listed Bio-AMD, Inc. has two majority owned United Kingdom (UK) subsidiaries. One is Bio-AMD Limited, which is a technology developer for medical diagnostic devices. The other is WOCU Limited, the owner of the WOCU®, a global currency data reference source for application in financial markets. The Company has positioned itself as a leading innovator in the field of reader technology development. Bio-AMD is based in the UK.

Bio-AMD continues to review its intellectual property (IP) strategy with the purpose of sufficiently protecting its key intangible assets. Any new IP generated is reviewed as far as possible to optimize the novel nature of the IP and freedom to operate in key jurisdictions.  

The Company is the 63 percent owner of the above-mentioned Bio-AMD Limited., a technology development company positioned in the fast growing Point of Care (PoC) medical diagnostics sector. PoC medical diagnostics is a multi-billion dollar international market. Currently, Bio-AMD has three proprietary technology platforms. These technology platforms include a disposable micro-fluidic test strip that has been adapted to measure prothrombin time (PT)/INR through a PoC blood coagulation monitoring device (COAG) enabling patient based, anticoagulant drug therapy monitoring.

Its platforms also include a Digital Strip Reader (DSR) that can read a wide array of lateral flow based immunoassay diagnostic test strips already in the PoC market including, but not limited to, cardiac markers, infectious diseases, drugs of abuse, and female wellbeing (pregnancy/ovulation testing) to provide semi-quantitative results.

The DSR technology platform utilizes a patented, proprietary method for reading and quantifying traditional chromatography based, nitro-cellulose, lateral-flow immunoassay tests, centered on what Bio-AMD believes to be a unique optical sensor arrangement. The DSR comprises a proprietary design incorporating sensors, diagnostics, and display and power management capabilities.

In addition, Bio-AMD is developing a fully quantitative Magnetic Immunoassay Detection System (MIDS). This was previously referred to as Magnetic Particle Reader or MPR. The Company’s expectation is that this will have a considerably enhanced sensitivity based on magnetic nano-particle manipulation and detection, which can interpret results on a quantitative basis.

Regarding the above-mentioned WOCU®, it is a global composite currency derivative covering the world’s top 20 economies. It is weighted sophisticatedly and logically based on International Monetary Fund (IMF) GDP figures. The WOCU’s low volatility offers market professionals and individuals a natural currency stabilization, hedging against exchange rate volatility and individual currency purchasing power.

On December 17, 2014, Bio Alternative Medical Devices Ltd. entered into a Master Agreement with Sysmex Corp. concerning the prospective development of the Company's coagulation diagnostic system (COAG). An expense contribution payment of roughly $1,000,000 was received from Sysmex on January 20, 2015.

Bio-AMD, Inc. (BIAD), closed Tuesday's trading session at $0.22, up 10.00%, on 336,650 volume with 64 trades. The average volume for the last 60 days is 93,796 and the stock's 52-week low/high is $0.0201/$0.262.

Glucose Health, Inc. (GLUC)

Today we are reporting on Glucose Health, Inc. (GLUC), here at the QualityStocks Daily Newsletter.

Headquartered in West Palm Beach, Florida, Glucose Health, Inc. manufactures dietary products. Its dietary products serve the large and growing market of proactive consumers who are aware of the serious implications of Type 2 diabetes and who are looking for natural health solutions. The Company’s products are manufactured in Gravette, Arkansas. Glucose Health’s shares trade on the OTC Markets Group’s OTCQB.

Glucose Health first conceived of a dietary supplement aimed at the large and developing market of proactive, healthy consumers interested in natural blood sugar maintenance or glucose health in 2011.  A proprietary formula consisting of five active ingredients was developed for the Company by Dr. Chandrasekhar Mallangi. The five ingredients are: extract of Cinnamon Tree Bark, Chromium Polynicotinate, and Soluble Corn Fiber, extracts of Green and White Teas, and Vitamin C.

For 25 years Dr. Mallangi managed the Nestle USA nutrition product development team responsible for products such as Carnation Instant Breakfast™ and Nestle Sweet Success™. In 2014, Glucose Health acquired the intellectual property (IP) for Glucose Health™ dietary supplement products. Glucose Health™ is developed and marketed for channel sales, via national and regional pharmacy retailers, in addition to direct to consumer sales.

Recently, Glucose Health announced the filing of its initial application for trademark protection related to its Glucose Health line of dietary products, with the United States Trademark and Patent Office (USPTO). If its application is successful and a trademark is awarded by the USPTO, a legal presumption of the Company’s ownership nationwide of Glucose Health, and the exclusive right to use a trademark on or in connection with all Glucose Health branded products, as stated in the registration, will exist.
Today, Glucose Health announced that it completed Food & Drug Administration (FDA) facility registration. This is a compliance procedure for manufacturers of dietary and nutritional supplements. FDA facility registration is the final step in a series of regulatory compliance procedures implemented by Glucose Health, starting in Q4 of 2014.

The Company expects to announce initial availability of the Blueberry and Strawberry product variations of its proprietary Glucose Health™ formula, in a "Value-Size" container format, within the next 30 days.

Glucose Health, Inc. (GLUC), closed Tuesday's trading session at $0.04, down 46.67%, on 10,250 volume with 2 trades. The average volume for the last 60 days is 10,011 and the stock's 52-week low/high is $0.0375/$2.00.


The QualityStocks
Company Corner


eCareer Holdings, Inc. (ECHI)

The QualityStocks Daily Newsletter would like to spotlight eCareer Holdings, Inc. (ECHI). Today, eCareer Holdings, Inc. closed trading at $0.30, even for the day. The stock’s average daily volume over the past 60 days is 1,168 and its 52-week low/high is $0.20/$4.00.

eCareer Holdings, Inc. reported today a 1,000-percent increase in traffic to its recently re-launched Openreq.com website, the leading news source for human resources, staffing and recruiting professionals. The company also highlighted recent performance results of its job board platform and the expansion of its full-time sales force.

eCareer Holdings, Inc. (ECHI) is an early-stage internet company working to organize the online hiring process by creating content-rich, profession-specific communities. By fully integrating its personalized career centers with matching branded professional and social networks, the company creates a solution for employers and professionals to enjoy the very best user experience.

The company’s development of branded career websites focuses on specialized “Internet Job Verticals,” which allow for some of the most effective job advertising platforms on the market. Through the use of superior technological solutions, eCareer Holdings plans to address the high demand for skilled professionals in a variety of narrow sectors while simultaneously attracting potential clients with strong advertising budgets.

Headquartered in Boca Raton, Florida, eCareer Holdings launched its first site, Openreq™, in January 2013. Using advanced software solutions, the site provides staffing, recruiting and human resource professionals with access to job openings in their desired sector. With a single post to Openreq, companies can reach over 1,300 sites including popular social networking destinations such as Indeed, Glassdoor, Facebook and SimplyHired. The company is also currently developing Cardiologist.com and BioFuel Zone, which are planned for release in the near future.

Led by a team of experienced executives headed by Chief Executive Officer Joseph J. Azzata, eCareer Holdings is persistently working to refine its effective job database solutions. With a range of unique features including industry news, social media groups, webinars, events, training programs and consolidated industry statistics, eCareer Holdings continues to engage in the design and development of revolutionary career websites aimed at recruiters, staffing companies and government agencies. Disclaimer

eCareer Holdings, Inc. Blog

eCareer Holdings, Inc. News:

eCareer Holdings Reports 1000% Increase in Openreq.com Site Traffic, Seeks to Expand Salesforce

eCareer Announces Engagement of QualityStocks Investor Relations Services

eCareer Relaunches Openreq With Revolutionary Job Matching Technology

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0032, off by 17.95%, on 4,714,397 volume with 64 trades. The stock’s average daily volume over the past 60 days is 4,044,630, and its 52-week low/high is $0.0008/$0.2998.

One World Holdings, Inc. subsidiary, The One World Doll Project, announced today that its CEO, Corinda Joanne Melton has issued an update letter to stockholders with overview details of 2015 revenue projections, Toy Fair performance, expanding retail distribution and more. The full text of the letter can be found on the One World Doll Project website at oneworlddolls.com.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

The One World Doll Project CEO Announces 2015 Revenue Projections in Stockholder Letter

The One World Doll Project and Doll Designer, Stacey Mcbride-Irby Featured in Huffington Post

The One World Doll Project Founder Interviews With CEOLIVE.TV; Updates on Toy Fair 2015

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.06, up 3.45%, on 237,329 volume with 29 trades. The stock’s average daily volume over the past 60 days is 638,935, and its 52-week low/high is $0.0555/$0.255.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial

International Stem Cell Corporation to Conduct Parkinson's Disease Clinical Study in Australia

International Stem Cell Corporation to Present at Biotech Showcase(TM) 2015

IFAN Financial, Inc. (IFAN)

The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.47, up 3.30%, on 281,825 volume with 86 trades. The stock’s average daily volume over the past 60 days is 721,152, and its 52-week low/high is $0.0114/$1.01.

IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.

Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.

Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.

IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer

IFAN Financial, Inc. Company Blog

IFAN Financial, Inc. News:

IFAN Financial, Inc. Announces Stock-Based Compensation Plan

IFAN Financial, Inc. Announces the Launch of New Website and Investor Relations Kit

IFAN Financial Enters Agreement to Provide Development Assistance to Card Collaborative International, LLC

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.1591, up 0.95%, on 12,562 volume with 9 trades. The stock’s average daily volume over the past 60 days is 40,024, and its 52-week low/high is $0.15/$1.00.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial

Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible

Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device

Sibling Group Holdings, Inc. (SIBE)

The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.0999, even for the day, on 30,2627 volume with 11 trades. The stock’s average daily volume over the past 60 days is 94,270, and its 52-week low/high is $0.06/$0.24.

Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.

Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.

Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.

IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer

Sibling Group Holdings, Inc. Company Blog

Sibling Group Holdings, Inc. News:

Sibling Group's Urban Planet Mobile Announces Partnership for Writing Planet in Hong Kong Secondary Schools

Sibling Group's Urban Planet Mobile(TM) Enters Indian Market, Announces New Mobile Distribution

Sibling Group Completes Urban Planet Mobile(TM) Acquisition, Appoints New CEO to Lead International Expansion

Coastal Integrated Services Inc. (COLV)

The QualityStocks Daily Newsletter would like to spotlight Coastal Integrated Services Inc. (COLV). Today, Coastal Integrated Services Inc. closed trading at $0.1035, off by 7.01%, on 3,600 volume with 2 trades. The stock’s average daily volume over the past 60 days is 80,054, and its 52-week low/high is $0.02/$3.75.

Coastal Integrated Services Inc. (COLV) is targeting the multi-billion dollar disposable beverage sector with the application of the unique technology and innovation developed by its wholly owned subsidiary Simply Lids, Inc. The company's specialty is disposable beverage lids in the food services industry.

Simply Lids' patented technologies provide a safer, more enjoyable drinking experience, without splashing or spills. The company's product designs also enable the added benefit of unique marketing opportunities that have never been realized in this industry sector.

The current standards for beverages are either a flimsy lid that requires the user to tear a pie-shaped mouth hole, or a tiny hole that you have to suck the liquid out like a child’s slippy cup. Frustrating and unsafe. The refreshingly improved design and customization options offered by Simply Lids allows users to enjoy their beverages like there is no lid at all while keeping liquid from splashing out.

The lids are aimed at a $20 billion dollar opportunity in the food services industry where there is astonishing no competition. The use of a new more environmentally friendly plastic with a lower carbon footprint also ensures that Simply Lids / COLV is working towards a more sustainable product for future generations. To date, Simply Lids has won the innovative new product award at the Seattle Coffee Fest Show, received designation as 10 out of 10 by Trend Hunter which indicates placement in the top 20 trends for 2014, and nomination for the prestigious Edison Award. Disclaimer

Coastal Integrated Services Inc. Company Blog

Coastal Integrated Services Inc. News:

Coastal Announces Subsidiary's Nomination for Prestigious Award

Coastal Subsidiary Provides Quote on Delivering Two Billion Coffee Lids

Coastal Integrated Services, Inc. (COLV) Announces Engagement of QualityStocks Investor Relations Services


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





INO.com Market Report


Market Authority

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251